Acadian Asset Management announces interest in Pharming
(ABM FN-Dow Jones) Acadian Asset Management announced its acquisition of a stake in Pharming Group for the first time. This emerged from a notification under the Financial Supervision Act, dated September 1.
Acadian announced a 3.06 percent equity stake with a voting power of 1.89 percent.
Acadian is a Boston-based asset manager with offices in the UK, Australia and Singapore. Acadian invests, among other things, in small businesses around the world.
Financial Control Law
The notification falls under the Control Disclosure Act, which has been subject to the Comprehensive Financial Supervision Act since January 1, 2007. Under this Act, shareholders with an interest greater than 3 percent must declare any change in their interest when the following thresholds are exceeded: 3, 5, and 10 and 15, 20, 25, 30, 40, 50, 60, 75 and 95 per cent. This applies to both accumulation and limitation of interest.
Source: ABM Financial News
From Beursplein 5, the editors of ABM Financial News closely follow developments on the stock exchanges, and the Amsterdam Stock Exchange in particular. The information in this column is not intended as professional investment advice or as a recommendation to make certain investments.
Zombie specialist. Friendly twitter guru. Internet buff. Organizer. Coffee trailblazer. Lifelong problem solver. Certified travel enthusiast. Alcohol geek.